Assessment of Global Lung Function Initiative (GLI) reference equations for diffusing capacity in relation to respiratory burden in the Swedish CArdioPulmonary bioImage Study (SCAPIS). Issue 2 (13th August 2020)

• Record Type: Journal Article
• Authors: Malinovschi, Andrei; Zhou, Xingwu; Bake, Björn; Bergström, Göran; Blomberg, Anders; Brisman, Jonas; Caidahl, Kenneth; Engström, Gunnar; Eriksson, Maria J.; Frølich, Andreas; Janson, Christer; Jansson, Kjell; Vikgren, Jenny; Lindberg, Anne; Linder, Robert; Mannila, Maria; Persson, Hans L.; Sköld, C. Magnus; Torén, Kjell; Östgren, Carl J.; Wollmer, Per; Engvall, Jan E.
• Is Part Of: European respiratory journal. Volume 56:Issue 2(2020)
• Publication Date: 2020-08-13
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.01995-2019
• Languages: English
• ISSNs: 0903-1936

Abstract

The Global Lung Function Initiative (GLI) has recently published international reference values for diffusing capacity of the lung for carbon monoxide ( D LCO ). Lower limit of normal (LLN), i.e. the 5th percentile, usually defines impaired D LCO . We examined if the GLI LLN for D LCO differs from the LLN in a Swedish population of healthy, never-smoking individuals and how any such differences affect identification of subjects with respiratory burden. Spirometry, D LCO, chest high-resolution computed tomography (HRCT) and questionnaires were obtained from the first 15 040 participants, aged 50–64 years, of the Swedish CArdioPulmonary bioImage Study (SCAPIS). Both GLI reference values and the lambda-mu-sigma (LMS) method were used to define the LLN in asymptomatic never-smokers without respiratory disease (n=4903, of which 2329 were women). Both the median and LLN for D LCO from SCAPIS were above the median and LLN from the GLI (p<0.05). The prevalence of D LCO <GLI LLN (and also <SCAPIS LLN) was 3.9%, while the prevalence of D LCO >GLI LLN but <SCAPIS LLN was 5.7%. Subjects with D LCO >GLI LLN but <SCAPIS LLN (n=860) had more emphysema (14.3% versus 4.5%, p<0.001), chronic airflow limitation (8.5% versus 3.9%, p<0.001) and chronic bronchitis (8.3% versus 4.4%, p<0.01) than subjects (n=13 600) with normal D LCO (>GLI LLN and >SCAPIS LLN). No differences were found with regard to physician-diagnosed asthma. The GLI LLN for D LCO is lower than the estimated LLN in healthy, never-smoking, middle-aged Swedish adults. Individuals with D LCO above the GLI LLN but below the SCAPIS LLN had, to a larger extent, an increased respiratory burden. This suggests clinical implications for choosing an adequate LLN for studied populations. The LLN for D LCO is above the GLI LLN in never-smoking, middle-aged Swedish adults. Individuals with D LCO above the GLI LLN but below the SCAPIS LLN had an increased burden of respiratory disease, suggesting clinical implications for the present findings. https://bit.ly/39B455B